[Bethanechol as treatment for urinary retention induced by a combination of neuroleptics and anticholinergics].
Seguí Montesinos
J
J
García Parés
G
G
de Pablo Rabassó
J
J
D000328:Adult; D018723:Bethanechol; D001626:Bethanechol Compounds / Q000627:therapeutic use*; D001712:Biperiden / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D010880:Piperidines / Q000009:adverse effects*; D014555:Urination Disorders / Q000188:drug therapy*
D001626:Bethanechol Compounds; D010880:Piperidines; D018723:Bethanechol; D001712:Biperiden; D006220:Haloperidol
El betanecol como tratamiento de la retención urinaria farmacológica provocada por la asociación de neurolépticos y anticolinérgicos.